EUVIMEDEUVIMED entdecken
Open Access

A self-amplifying nerve-fibroblast circuit drives colorectal cancer progression

Hiroki Kobayashi, Tadashi Iida, Yosuke Ochiai, Akihiro Sakai, Ruth A White, Yi Zeng, Xiaofei Zhi, Jin Qian, Feijing Wu, Biyun Zheng, Junya Arai, Masahiro Hata und 14 weitere

Cancer Cell · 2026-09 · 44 (9) · 1862-1881.e18

DOI: 10.1016/j.ccell.2026.06.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026-09. Verfasst von Hiroki Kobayashi und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Columbia University Medical Center, New York, NY …. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nerves and cancer-associated fibroblasts (CAFs) have each been shown to regulate cancer progression directly. However, whether these cells interact to control tumor progression remains largely unknown. We show that in colorectal cancer (CRC), cholinergic stimulation induces CHRM3/Gq-dependent NTN1 secretion from CAFs, which in turn enhances intratumor cholinergic innervation. Within this feedforward loop, cholinergic stimulation promotes CRC growth directly through tumoral CHRM3/Gq-mediated YAP activation, while CAF-derived NTN1 promotes CRC growth and epithelial-to-mesenchymal transition-like programs via UNC5B-PI3K/AKT signaling. Chemogenetic activation of cholinergic neurons or fibroblast activation of the M3 receptor/Gq promotes tumoral YAP and AKT signaling and CRC progression. Conversely, blocking CHRM3 or NTN1 suppresses these pathways and improves mouse survival. In human CRC, high NTN1 expression is associated with a mesenchymal-like subtype and poor patient outcomes. These findings suggest that the neuro-mesenchymal interaction is central to CRC progression and could be therapeutically targeted with a CHRM3 antagonist or NTN1-blocking antibody.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCancer-Associated FibroblastsHumansAnimalsMiceDisease ProgressionEpithelial-Mesenchymal TransitionSignal TransductionReceptor, Muscarinic M3Cell Line, Tumor

Stichwörter der Autor:innen

EMTNetrin-1Netrin-1 antibody NP137acetylcholinecancer neurosciencecholinergic nervescolorectal cancerepithelial-to-mesenchymal transitionfibroblastsmuscarinic receptor 3tumor microenvironment

Substanzen

Receptor, Muscarinic M3CHRM3 protein, human

Autor:innen und Institutionen

  • Division of Digestive and Liver Diseases, Department of Medicine and Irving Cancer Research Center, Columbia University Medical Center, New York, NY 10032, USA; Columbia University Digestive and Liver Disease Research C…
  • Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550…
  • Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.
  • Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.
  • Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.
  • Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • DeGregorio Family Foundation
  • Japan Agency for Medical Research and Development
  • National Institutes of Health National Cancer Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Kobayashi, H., Iida, T., Ochiai, Y., Sakai, A., White, R. A., Zeng, Y., Zhi, X., Qian, J., Wu, F., Zheng, B., Arai, J., Hata, M., Zheng, H., Zhang, P., Li, S., Waterbury, Q. T., LaBella, J. S., Nagendra, H., Zamechek, L. B., …, & Wang, T. C. (2026). A self-amplifying nerve-fibroblast circuit drives colorectal cancer progression. Cancer Cell, 44(9), 1862-1881.e18. https://doi.org/10.1016/j.ccell.2026.06.018

Vancouver

Kobayashi H, Iida T, Ochiai Y, Sakai A, White RA, Zeng Y, et al. A self-amplifying nerve-fibroblast circuit drives colorectal cancer progression. Cancer Cell. 2026;44(9):1862-1881.e18. doi:10.1016/j.ccell.2026.06.018

BibTeX
@article{Kobayashi2026,
  author = {Kobayashi, Hiroki and Iida, Tadashi and Ochiai, Yosuke and Sakai, Akihiro and White, Ruth A and Zeng, Yi and Zhi, Xiaofei and Qian, Jin and Wu, Feijing and Zheng, Biyun and Arai, Junya and Hata, Masahiro and Zheng, Hualong and Zhang, Puran and Li, Shuang and Waterbury, Quin T and LaBella, Jonathan S and Nagendra, Harry and Zamechek, Leah B and Ogura, Atsushi and Kanda, Mitsuro and Eltzschig, Holger K and Woods, Susan L and Worthley, Daniel L and Enomoto, Atsushi and Wang, Timothy C},
  title = {A self-amplifying nerve-fibroblast circuit drives colorectal cancer progression},
  journal = {Cancer Cell},
  year = {2026},
  volume = {44},
  number = {9},
  pages = {1862--1881.e18},
  doi = {10.1016/j.ccell.2026.06.018}
}
Kostenlos starten →